Farms.com Home   News

Dairy Industry 'Closer To Normal' As Pandemic Continues

Dairy Industry 'Closer To Normal' As Pandemic Continues

By Kailey Foster

When stay-at-home orders were first enacted back in March, it meant places like schools and restaurants were also forced to close in-house operations. This caused the dairy industry to redirect their product market to try and reduce financial loss. In cases where this was not successful, milk dumping often occured.

Karianne Fallow, the CEO of Dairy West said the Utah dairy industry was able to remain stable throughout these hardships. And while milk dumping happened in across the country, many Utah milk producers were able to avoid this through creative solutions.

“I would give credit to the farmers to families food box program launched by the USDA, and the Curds and Kindness program. When we can move products on market,  that is a way to keep milk prices up or stable,” said Fallow.

Fallow added that dairy farmers are resilient and optimistic people.

“We do have a number of farmers who are also using this time to reinvest in their business so that they can prepare for the future,” said Falllow.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.